Cargando…

Antipsychotic use and psychiatric disorders in COVID-19

Detalles Bibliográficos
Autores principales:	Ferraris, Augusto, Angriman, Federico, Szmulewicz, Alejandro G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906667/ https://www.ncbi.nlm.nih.gov/pubmed/33665642 http://dx.doi.org/10.1016/S2666-7568(20)30063-5

Ejemplares similares

Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? – Authors' reply
por: Yang, Huazhen, et al.
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on
por: Boland, Xavier, et al.
Publicado: (2021)

COVID-19 vaccine uptake in patients with psychiatric disorders admitted to or residing in a university psychiatric hospital
por: Mazereel, Victor, et al.
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

Antipsychotic prescribing to people with dementia during COVID-19
por: Howard, Robert, et al.
Publicado: (2020)

Disentangling the complex bidirectional associations between COVID-19 and psychiatric disorder
por: Lo, Yi-Fan, et al.
Publicado: (2021)

Disentangling the complex bidirectional associations between COVID-19 and psychiatric disorder – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Farhan, Rida, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Velayudhan, Latha, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Pattni, Vijay, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): Recommendations for health care professionals
por: Paez, Andrea Falconi, et al.
Publicado: (2022)

Unravelling potential severe psychiatric repercussions on healthcare professionals during the COVID-19 crisis
por: Anmella, G., et al.
Publicado: (2020)

Psychiatric Disorder Criteria and their Application to Research in Different Racial Groups
por: Low, Nancy CP, et al.
Publicado: (2007)

Mechanisms for substance use disorders in COVID-19
por: Lin, Zhicheng
Publicado: (2021)

Curbing and preventing psychiatric disorders through healthier eating and sleeping habits
por: Tahir, Muhammad Saad, et al.
Publicado: (2022)

The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics
por: Kim, Eunju, et al.
Publicado: (2023)

Management measures for non-medical staff on psychiatric hospital wards during the COVID-19 pandemic
por: Yang, Lei, et al.
Publicado: (2020)

Community mental health services: Access for acute psychiatric care during the COVID-19 lockdown
por: Sekharan, Lokesh, et al.
Publicado: (2022)

COVID-19-related health worries compound the psychiatric distress experienced by families of high-risk infants
por: Liu, Cindy H., et al.
Publicado: (2021)

Public Interest in Psychiatric Treatments During COVID-19 Pandemic: An Analysis of Changes Between 2020 and 2021
por: Becerra-García, Juan Antonio, et al.
Publicado: (2023)

The time to act: Early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´s letter to the editor (Llach and Anmella, 2022)
por: Paez, Andrea Falconi, et al.
Publicado: (2022)

Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model
por: Mirabzadeh, Arash, et al.
Publicado: (2013)

Psychiatric disorders and aggression in the printed media: is there a link? a central European perspective
por: Nawka, Alexander, et al.
Publicado: (2012)

Significance and stability of deep learning-based identification of subtypes within major psychiatric disorders
por: Winter, Nils R., et al.
Publicado: (2022)

Neuropsychiatric disorders and COVID-19
por: Charlton, Elizabeth, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Finsterer, Josef
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Burchill, Ella, et al.
Publicado: (2021)

Atypical Antipsychotics are Disproportionately Associated with Patients Reporting Increased Eating Drives
por: Yum, Sun Young, et al.
Publicado: (2021)

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
por: Hirjak, Dusan, et al.
Publicado: (2021)

The use of long-acting injectable antipsychotics in an acute psychiatric unit
por: Ortega-Hernández, G., et al.
Publicado: (2023)

RESTRAINING PSYCHIATRIC PATIENTS
por: Bhide, Ajit V.
Publicado: (1994)

No psychological vaccination: Vaccine hesitancy is associated with negative psychiatric outcomes among Israelis who received COVID-19 vaccination
por: Palgi, Yuval, et al.
Publicado: (2021)

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
por: Tajika, Aran, et al.
Publicado: (2023)

RE: An intercultural perspective towards supporting antipsychotic medication adherence in clinical practice
por: Alachkar, Mustafa
Publicado: (2023)

Medical education in movement disorders during the COVID-19 pandemic
por: Zuzuárregui, José Rafael P., et al.
Publicado: (2020)

Estimating the Case Fatality Risk of COVID-19 among Mechanically Ventilated Patients
por: Angriman, Federico, et al.
Publicado: (2021)

The times they are a-changin: implementing new psychiatric rehabilitation models within a community care in the post COVID-19 era
por: Pelizza, Lorenzo, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

Characterising neuropsychiatric disorders in patients with COVID-19
por: Wade, Dorothy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vfj5po5jmvo3jlru0c2ffmofoa